Blog

  • Blog
    On the Front Lines: Responding to COVID-19
    14 September 2020
    With personal protective equipment, radio broadcasts and innovative mosquito net campaigns, countries are fighting COVID-19, shoring up health systems, and mitigating the impacts on lifesaving HIV, TB and malaria programs. The Global Fund is supporting these efforts with immediate funding. Here’s where countries are directing that financial support to help stop the pandemic by uniting to fight.
  • Blog
    Eswatini Meets Global 95-95-95 HIV Target
    14 September 2020
    Eswatini, a tiny country of just over a million people in southern Africa, has one of the highest HIV prevalence rates in the world: 27% of adults live with the disease.
  • Blog
    Myanmar Makes Major Progress Fighting Malaria
    14 September 2020
    Ten years ago, more than 3,800 people died from malaria in Myanmar every year. Today, that number has dropped to approximately 170.
  • Blog
    An Urgent Plea from a South African Health Worker Fighting COVID-19 and TB
    21 August 2020
    In Cape Town, South Africa, Nombasa Krune-Dumile, a drug-resistant tuberculosis counselor who has dedicated her life to supporting tuberculosis (TB) patients, says COVID-19 has devastated health systems and upended normal operations of her work.
  • Blog
    Strengthening Data Systems to Save Lives
    21 July 2020
    Building resilient and sustainable systems for health has never been more critical. The COVID-19 pandemic has disrupted supply chains globally and threatens to reverse the hard-won gains made in the fight against HIV, TB and malaria. In countries where weak health systems are already overstretched, the knock-on impact of COVID-19 threatens to be catastrophic.
  • Blog
    Lifeline During Lockdown: Delivering Medicines During COVID-19
    06 July 2020
    COVID-19 lockdowns are having a catastrophic impact on key and vulnerable populations. Restrictive measures are preventing some communities from accessing and affording enough food or medicine, causing disruptions to lifesaving treatments. When patients’ treatments are disrupted, they can develop drug resistance, spread the disease to others, or – in the case of HIV-positive pregnant women and new mothers – pass the illness to their babies.